The Drive to Discover. The Experience to Deliver.
Our Press Room provides the latest information about Incyte's products and programs, financial position and recent developments. You will also find our most recent and archived press releases.
If you are a member of the media and you would like to arrange an interview or learn more about Incyte Corporation, please contact Pamela M. Murphy, Vice President of Investor Relations and Corporate Communications, at 302.498.6944 or email@example.com.
- About Incyte
- Jakafi® (ruxolitinib)
- Disease Education